Skip to main content

Table 4 Incidence of serious adverse events during each phase of the study

From: Decreasing severe pain and serious adverse events while moving intensive care unit patients: a prospective interventional study (the NURSE-DO project)

  Phase 1
(baseline)
n= 182
Phase 2
(intervention)
n= 129
Phase 3
(adjustment)
n= 170
Phase 4
(consolidation)
n= 149
P
1-2
P
1-3
P
1-4
Cardiac arrest, n (%) 2 (1%) 0 (0%) 0 (0%) 0 (0%)    
Arrhythmias, n (%) 3 (2%) 4 (3%) 1 (1%) 0 (0%)    
Tachycardia, n (%) 5 (3%) 5 (4%) 3 (2%) 6 (4%)    
Bradycardia, n (%) 0 (0%) 2 (2%) 0 (0%) 0 (0%)    
Hypertension, n (%) 14 (8%) 2 (2%) 6 (4%) 11 (7%)    
Hypotension, n (%) 8 (4%) 5 (4%) 2 (1%) 9 (6%)    
Oxygen desaturation, n (%) 19 (10%) 15 (12%) 8 (5%) 6 (4%)    
Bradypnea, n (%) 2 (1%) 6 (5%) 0 (0%) 0 (0%)    
Ventilatory distress, n (%) 24 (13%) 13 (10%) 15 (9%) 2 (1%)    
At least one event, n (%) 68 (37%) 36 (28%) 29 (17%) 31 (21%) 0.09 < 0.001 0.005
  1. Statistical analysis was performed using a generalized linear mixed-effects model for repeated measures.